Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Basal insulin substitution with glargine or continuous subcutaneous insulin infusion in adult type 1 diabetes patients-a randomized controlled trial.

Bragd J, von Döbeln A, Lins PE, Adamson U, Bergström J, Oskarsson P.

Diabetes Technol Ther. 2010 Sep;12(9):689-93. doi: 10.1089/dia.2010.0062.

PMID:
20687863
2.

Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes.

Pickup JC, Renard E.

Diabetes Care. 2008 Feb;31 Suppl 2:S140-5. doi: 10.2337/dc08-s235. Review.

PMID:
18227475
3.
4.

Basal insulin treatment in type 2 diabetes.

Hedrington MS, Pulliam L, Davis SN.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S33-42. doi: 10.1089/dia.2011.0062. Review.

5.

Clinical experience with insulin glargine in type 1 diabetes.

Garg S, Moser E, Dain MP, Rodionova A.

Diabetes Technol Ther. 2010 Nov;12(11):835-46. doi: 10.1089/dia.2010.0135. Epub 2010 Oct 22. Review.

6.

Continuous subcutaneous insulin infusion (CSII) pumps.

Valla V.

Adv Exp Med Biol. 2012;771:414-9. Review.

PMID:
23393693
7.

Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps.

Valla V.

Exp Diabetes Res. 2010;2010:178372. doi: 10.1155/2010/178372. Epub 2010 May 26. Review.

8.

[New developments in the treatment and monitoring of type 1 diabetes mellitus].

Otto-Buczkowska E, Jarosz-Chobot P, Tucholski K.

Endokrynol Pol. 2008 May-Jun;59(3):246-53. Review. Polish.

PMID:
18615401
9.

Continuous subcutaneous insulin infusion for managing diabetes: women's health implications.

Hood DG.

Nurs Womens Health. 2012 Aug-Sep;16(4):308-18. doi: 10.1111/j.1751-486X.2012.01749.x. Review.

PMID:
22900807
10.
11.

CSII as an Alternative Therapeutic Strategy for Managing Type 2 Diabetes: Adding the Indian Experience to a Global Perspective.

Kesavadev J, Shankar A, Sadasrian Pillai PB, Saboo B, Joshi S, Krishnan G, Jothydev S.

Curr Diabetes Rev. 2016;12(4):312-314. Review.

PMID:
26643928
12.

Identifying patients for insulin pump therapy.

Morrison G, Weston P.

Nurs Times. 2013 Mar 12-18;109(10):14, 16, 18. Review.

PMID:
23560341
13.
14.

New insulin analogues and perioperative care of patients with type 1 diabetes.

Killen J, Tonks K, Greenfield JR, Story DA.

Anaesth Intensive Care. 2010 Mar;38(2):244-9. Review. Erratum in: Anaesth Intensive Care. 2010 Jul;38(4):770. Greenfield, J [corrected to Greenfield JR].

15.

Diabetes Device Interoperability for Improved Diabetes Management.

Silk AD.

J Diabetes Sci Technol. 2015 Jul 15;10(1):175-7. doi: 10.1177/1932296815595051. Review.

16.

New developments in type 1 (insulin-dependent) diabetes.

Silverstein JH, Rosenbloom AL.

Clin Pediatr (Phila). 2000 May;39(5):257-66. Review.

PMID:
10826072
17.

The Third Injection Technique Workshop in Athens (TITAN).

Frid A, Hirsch L, Gaspar R, Hicks D, Kreugel G, Liersch J, Letondeur C, Sauvanet JP, Tubiana-Rufi N, Strauss K.

Diabetes Metab. 2010 Sep;36 Suppl 2:S19-29. doi: 10.1016/S1262-3636(10)70003-3.

PMID:
20933206
18.

Continuous subcutaneous insulin infusion: Special needs for children.

Adolfsson P, Ziegler R, Hanas R.

Pediatr Diabetes. 2017 Jun;18(4):255-261. doi: 10.1111/pedi.12491. Epub 2017 Apr 20. Review.

PMID:
28425167
19.

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.

King AB, Kuroda A, Matsuhisa M, Hobbs T.

Curr Diab Rep. 2016 Sep;16(9):83. doi: 10.1007/s11892-016-0772-0. Review.

Supplemental Content

Support Center